AGRYLIN

This brand name is authorized in Brazil, Canada, Hong Kong, Japan, New Zealand, Singapore, United States, South Africa

Active ingredients

The drug AGRYLIN contains one active pharmaceutical ingredient (API):

1 Anagrelide
UNII VNS4435G39 - ANAGRELIDE HYDROCHLORIDE ANHYDROUS

Anagrelide is an inhibitor of cyclic AMP phosphodiesterase III and suppress expression of transcription factors including GATA-1 and FOG-1 required for megakaryocytopoiesis, ultimately leading to reduced platelet production.

Read about Anagrelide

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
AGRYLIN Capsule FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01XX35 Anagrelide L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XX Other antineoplastic agents
Discover more medicines within L01XX35

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 501121020037717, 531600101111318
Country: CA Health Products and Food Branch Identifier(s): 02236859
Country: HK Department of Health Drug Office Identifier(s): 51737
Country: JP 医薬品医療機器総合機構 Identifier(s): 4299003M1020
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 14499
Country: SG Health Sciences Authority Identifier(s): 12525P
Country: US FDA, National Drug Code Identifier(s): 54092-063
Country: ZA Health Products Regulatory Authority Identifier(s): 33/8/0289

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.